Carna Biosciences, Inc. (TYO:4572)
Japan
· Delayed Price · Currency is JPY 280.00
-4.00 (-1.41%)
May 2, 2025, 3:30 PM JST
Carna Biosciences Revenue
In the year 2024, Carna Biosciences had annual revenue of 636.00M JPY, down -60.86%. Carna Biosciences had revenue of 148.78M in the quarter ending December 31, 2024, a decrease of -83.72%.
Revenue
636.00M
Revenue Growth
-60.86%
P/S Ratio
8.41
Revenue / Employee
10.10M
Employees
63
Market Cap
5.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 636.00M | -989.00M | -60.86% |
| Dec 31, 2023 | 1.63B | 239.00M | 17.24% |
| Dec 31, 2022 | 1.39B | -631.00M | -31.28% |
| Dec 31, 2021 | 2.02B | 884.00M | 78.02% |
| Dec 31, 2020 | 1.13B | -2.07B | -64.67% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,579.02B |
| HOYA Corporation | 869.37B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 993.33B |